Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Qualigen Therapeutics Inc. (QLGN)

  • Technical Exchange News
  • Dec. 10, 2024, 18:45 UTC
  • 47
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

Comment Full text

Ocean Biomedical Inc (OCEA)

  • Technical Exchange News
  • Dec. 10, 2024, 18:45 UTC
  • 50
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Deficient and Delinquent.

Comment Full text

Meihua International Medical Technologies Co Ltd (MHUA)

  • Technical Exchange News
  • Dec. 10, 2024, 18:44 UTC
  • 51
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Biora Therapeutics Inc (BIOR)

  • Technical Exchange News
  • Dec. 10, 2024, 18:44 UTC
  • 51
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

180 Life Sciences Corp. (ATNF)

  • Technical Exchange News
  • Dec. 10, 2024, 18:43 UTC
  • 49
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

180 Life Sciences Corp. (ATNFW)

  • Technical Exchange News
  • Dec. 10, 2024, 18:43 UTC
  • 52
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Apollomics Inc (APLM)

  • Technical Exchange News
  • Dec. 10, 2024, 18:43 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Dec. 10, 2024, 02:38 UTC
  • 49
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • Dec. 10, 2024, 02:38 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Dec. 09, 2024, 18:40 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text
  • Previous
  • 299
  • 300
  • 301
  • 302
  • 303
  • Next

Search

News categories

  • Technical Exchange News(10898)
  • Event(2311)
  • SEC News(190219)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124832)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin